| Trial ID: | L0911 |
| Source ID: | NCT01992809
|
| Associated Drug: |
Polyunsaturated Fatty Acids
|
| Title: |
Polyunsaturated Fatty Acid (Pufa) Omega 3 in the Reduction of the Inflammatory Component of the Nonalcoholic Steatohepatitis (Nash):Randomized Placebo Controlled Study
|
| Acronym: |
OMEGA 3 NASH
|
| Status: |
Not recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Fatty Liver
|
| Interventions: |
Dietary Supplement: Omega 3
|
| Outcome Measures: |
Efficacy in reduce inflammatory component of NASH for NAS scoreInflammatory systemic profile
|
| Sponsor/Collaborators: |
University of Sao Paulo General Hospital
|
| Gender: |
All
|
| Age: |
18 Years70 Years
|
| Phases: |
Phase 3
|
| Enrollment: |
60
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Double Blind (Caregiver, Outcomes Assessor), Primary Purpose: Treatment
|
| Start Date: |
07/11/2013
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
19 February 2015
|
| Locations: |
Brazil
|
| URL: |
http://clinicaltrials.gov/show/NCT01992809
|
